PACS Group Inc PACS Stock Analysis
- NYSE
- Stock
- Market closed · opens Monday 9:30 AM ET
$46.61 down $1.15, 2.40% on Oct 16
Last price · Previous close $47.75
- Market cap
- At the last price
- P/E ratio
- 27.25On last 12 months’ EPS
- Diluted EPS
- $1.71Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$46.61down $1.15, 2.40%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$47.75Oct 15
- Volume1.70MOct 15 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume798.63KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $10.31 to $49.49; now $46.61
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the last price. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
PACS beat the S&P 500 in all 4 periods.
| Period | PACS and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PACS: up 9.1% S&P 500: up 1.5% | PACS beat the S&P 500 by 7.6 percentage points Beat |
| 3M | PACS: up 2.1% S&P 500: up 1.9% | PACS beat the S&P 500 by 0.2 percentage points Beat |
| YTD | PACS: up 21.4% S&P 500: up 12.8% | PACS beat the S&P 500 by 8.6 percentage points Beat |
| 1Y | PACS: up 274.3% S&P 500: up 16.8% | PACS beat the S&P 500 by 257.5 percentage points Beat |
$10,000 invested in PACS a year ago (Oct 16, 2025) would be worth about $37,434 as of , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,678.
PACS beat the S&P 500 in all 4 periods.
| Period | PACS and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PACS: up 9.1% S&P 500: up 1.2% | PACS beat the S&P 500 by 7.9 percentage points Beat |
| 3M | PACS: up 2.1% S&P 500: up 1.7% | PACS beat the S&P 500 by 0.4 percentage points Beat |
| YTD | PACS: up 21.4% S&P 500: up 11.9% | PACS beat the S&P 500 by 9.5 percentage points Beat |
| 1Y | PACS: up 274.3% S&P 500: up 15.5% | PACS beat the S&P 500 by 258.8 percentage points Beat |
$10,000 invested in PACS a year ago (Oct 16, 2025) would be worth about $37,434 as of , not counting dividends. The same amount in the S&P 500 would be worth about $11,553.
All-time high
$48.45
Closing high on . Now 3.8% below that record.
Split-adjusted daily closes since Apr 11, 2024.
Stock splits
PACS hasn’t split since its price history begins in 2024.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $5.55Bup 15.2%
- Net income
- $269.17Mup 103.5%
- Diluted EPS
- $1.71up 106.0%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $1.03B | $15.62M | $0.10 |
| Q4 FY24 (Dec 31, 2024) | $1.21B | $37.20M | $0.25 |
| Q1 FY25 (Mar 31, 2025) | $1.28B | $28.47M | $0.17 |
| Q2 FY25 (Jun 30, 2025) | $1.31B | $50.96M | $0.31 |
| Q3 FY25 (Sep 30, 2025) | $1.34B | $52.41M | $0.32 |
| Q4 FY25 (Dec 31, 2025) | $1.36B | $59.70M | $0.42 |
| Q1 FY26 (Mar 31, 2026) | $1.42B | $80.70M | $0.50 |
| Q2 FY26 (Jun 30, 2026) | $1.43B | $76.37M | $0.47 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $1.17B | $47.95M | $0.37 |
| FY22 (Dec 31, 2022) | $2.42B | $150.50M | $1.17 |
| FY23 (Dec 31, 2023) | $3.11B | $112.87M | $0.88 |
| FY24 (Dec 31, 2024) | $4.09B | $55.76M | $0.38 |
| FY25 (Dec 31, 2025) | $5.29B | $191.54M | $1.22 |
Margins
- Gross 16.6%
- Operating 7.4%
- Net 4.8%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $122.22MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$573.25MLast 12 months
- Capital spending$451.03MLast 12 months
- 2.2%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $0.00Last 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
0% of free cash flow
Balance sheet
- $164.45MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$3.25BAs of Jun 30, 2026
- Net debt$3.09BAs of Jun 30, 2026
- 0.91As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 2.93As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 6 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 27.2%Last 12 months
Over the last 12 months, PACS Group’s net income was 27.2% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 4.8%Last 12 months
Over the last 12 months, PACS Group’s net income was 4.8% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About PACS Group Inc
PACS is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. Founded in 2013, PACS is one of the largest post-acute platforms in the United States. Its independent subsidiaries operate 276 post-acute care facilities across 15 states serving up to 29,000 patients daily.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Utah, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE
- Asset type
- Common stock
- Price history since
PACS news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
PACS stock FAQ
What is PACS stock’s price today?
PACS Group (PACS) traded at $46.61 as of , down $1.15 (2.40%) from the previous close of $47.75. Over the past 52 weeks it has traded between $10.31 and $49.49.
What is PACS’s P/E ratio?
PACS trades at 27.3 times its diluted earnings over the four quarters to ($1.71 per share), at the last price on . (How the P/E ratio works.)
How much revenue does PACS Group make?
PACS Group reported $5.6 billion of revenue over the four quarters to , up 15.2% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $1.4 billion, up 9.1% from a year earlier.
Is PACS Group profitable?
Yes. PACS Group earned $269.2 million of net income over the four quarters to , a net margin of 4.8%, and its operating margin was 7.4% (what margins tell you).
What are PACS’s earnings per share?
PACS’s diluted earnings per share were $1.71 over the four quarters to , compared with $0.83 in the twelve months before. The latest quarter (Q2 FY26) brought $0.47 per share, against $0.31 a year earlier (how EPS works).
Does PACS pay a dividend?
PACS Group hasn’t paid a dividend in the last twelve months.
What is PACS’s 52-week high and low?
Over the past 52 weeks PACS has traded as low as $10.31 and as high as $49.49. At $46.61 as of , it is 5.8% below that high and 352.0% above the low.
What is PACS’s all-time high?
PACS’s highest closing price was $48.45 on , adjusted for stock splits. At $46.61 as of , it is 3.8% below that record.
Has PACS stock ever split?
No. PACS hasn’t split since its price history begins in 2024.
How has PACS stock performed?
Including dividends and measured to the last price on , PACS has returned +21.4% so far this year and +274.3% over the past year. Over the same periods the S&P 500, measured by SPY, returned +12.8% and +16.8%. Past performance doesn’t predict future returns.
What sector and industry is PACS Group in?
PACS Group is in the Healthcare sector and the Medical Care Facilities industry, and is headquartered in Utah, USA.
What exchange does PACS trade on?
PACS Group trades on the NYSE under the ticker symbol PACS. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.